Since the third quarter, DRAM manufacturers around the world have been downing pepto-bismol as the price slump takes its toll. In Taiwan, small to mid-sized companies have already taken quite a blow, so much so that diversification is no longer fun...
The article requires paid subscription. Subscribe Now
